AAAAAA
Results:
1-10
|
Results: 10
Authors:
McGaughey, DS
Nikcevich, DA
Long, GD
Vredenburgh, JJ
Rizzieri, D
Smith, CA
Broadwater, G
Loftis, FS
McDonald, C
Morris, AK
Folz, RJ
Chao, NJ
Citation: Ds. Mcgaughey et al., Inhaled steroids as prophylaxis for delayed pulmonary toxicity syndrome inbreast cancer patients undergoing high-dose chemotherapy and autologous stem cell transplantation, BIOL BLOOD, 7(5), 2001, pp. 274-278
Authors:
Hayes, DF
Yamauchi, H
Broadwater, G
Cirrincione, CT
Rodrigue, SP
Berry, DA
Younger, J
Panasci, LL
Millard, F
Duggan, DB
Norton, L
Henderson, IC
Citation: Df. Hayes et al., Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and leukemia group B study 8662, CLIN CANC R, 7(9), 2001, pp. 2703-2711
Authors:
Harris, LN
Liotcheva, V
Broadwater, G
Ramirez, MJ
Maimonis, P
Anderson, S
Everett, T
Harpole, D
Moore, MB
Berry, DA
Rizzeri, D
Vredenburgh, JJ
Bentley, RC
Citation: Ln. Harris et al., Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy, J CL ONCOL, 19(6), 2001, pp. 1698-1706
Authors:
Connor, CE
Norris, JD
Broadwater, G
Willson, TM
Gottardis, MM
Dewhirst, MW
McDonnell, DP
Citation: Ce. Connor et al., Circumventing tamoxifen resistance in breast cancers using antiestrogens that induce unique conformational changes in the estrogen receptor, CANCER RES, 61(7), 2001, pp. 2917-2922
Authors:
Guidi, AJ
Berry, DA
Broadwater, G
Perloff, M
Norton, L
Barcos, MP
Hayes, DF
Citation: Aj. Guidi et al., Association of angiogenesis in lymph node metastases with outcome of breast cancer, J NAT CANC, 92(6), 2000, pp. 486-492
Authors:
Blackwell, KL
Haroon, ZA
Shan, S
Saito, W
Broadwater, G
Greenberg, CS
Dewhirst, MW
Citation: Kl. Blackwell et al., Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models, CLIN CANC R, 6(11), 2000, pp. 4359-4364
Authors:
Blackwell, K
Haroon, Z
Broadwater, G
Berry, D
Harris, L
Iglehart, JD
Dewhirst, M
Greenberg, C
Citation: K. Blackwell et al., Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status, J CL ONCOL, 18(3), 2000, pp. 600-608
Authors:
Berry, DA
Muss, HB
Thor, AD
Dressler, L
Liu, ET
Broadwater, G
Budman, DR
Henderson, IC
Barcos, M
Hayes, D
Norton, L
Citation: Da. Berry et al., HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer, J CL ONCOL, 18(20), 2000, pp. 3471-3479
Authors:
Carter, DL
Marks, LB
Bean, JM
Broadwater, G
Hussein, A
Vredenburgh, JJ
Peters, WP
Prosnitz, LR
Citation: Dl. Carter et al., Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue, J CL ONCOL, 17(3), 1999, pp. 887-893
Authors:
Rizzieri, DA
Vredenburgh, JJ
Jones, R
Ross, M
Shpall, EJ
Hussein, A
Broadwater, G
Berry, D
Petros, WP
Gilbert, C
Affronti, ML
Coniglio, D
Rubin, P
Elkordy, M
Long, GD
Chao, NJ
Peters, WP
Citation: Da. Rizzieri et al., Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support, J CL ONCOL, 17(10), 1999, pp. 3064-3074
Risultati:
1-10
|